Pharmacology Of Drugs Acting On Uterus- Mbbs

  • Uploaded by: Dr.U.P.Rathnakar.MD.DIH.PGDHM
  • 0
  • 0
  • May 2020
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Pharmacology Of Drugs Acting On Uterus- Mbbs as PDF for free.

More details

  • Words: 724
  • Pages: 23
Drugs acting on the uterus

Dr.U.P.Rathnakar MD. DIH. PGDHM K.M.C.Mangalore

Drugs Acting on the Uterus • Introduction • Stimulants 1. Oxytocin 2. Desamino-oxytocin 3. Ergometrine, Methyl ergometrine 4. Prostaglandins • Tocolytics (Relaxants) 1. Adr.agonists, Ca++ blockers, Magnesium sulfate, oxytocin antagonist, Misc *

Drugs

• Drugs ---- Endometrium or myometrium • Endometrium--- Estrogen or progesterone, and antagonists • Myometrium1. Indirectly acting-Symp or P.symp [ANS drugs-non selective-other systems+] 2. Directly acting 1. Ut.stimulants (oxytocics) 2. Ut. Relaxants (Tocolytics)*

UTERINE STIMULANTS

• Post. Pit. Hormone- Oxytocin • Ergot alkaloids- Ergometrine (Ergonovine), Methylergometrine • Prostaglandins- PGE2, PGF2a, 15-Methyl PGF2a, Misoprostol • Miscellaneous- Alcohol, Ethacridine, Quinine*

Oxytocin (Quick birth) • Post Pit → Oxytocin and Vasopressin • Synth. In hypothalumus → Transported and stored in post. Pitutary • Released after distension of the cervix and vagina → birth → • Stimulation of the nipples breastfeeding, (Letdown or milk ejection reflex)*

Pharmacokinetics • Not absorbed orally • Administerd by i.v, i.m, rarely nasal route. • Not bound to plasma protienst1/2- 2 -5mts • Metabolized in liver and kidney*

Pharmacodynamics • Acts → GPCR • Small doses → Frequency and force • Large doses → Sustained contraction • Mammary alveoli-myoepethelial cells → contraction • Neurotransmitter in brain*

Ph. Actions: • Uterus: • Sensitivity increases as pregnancy progresses9 fold [early&nonpregnant-resistant] • Receptors increase- 30 times • Estrogen facilitates, progesterone inhibits • Lower segment not contracted • Breast- Milk ejection • CVS- Hypotension • Kidney- ADH like • CNS*

Clinical uses of Oxytocin • 2. 3. 4. 5.

To induce, augment labor in Premature rupture Isoimmunization Placental insufficiency Toxemia, post maturity, DM Verify fetal lung maturity, Exclude C.IsPosition abnormalities, CPD,distress etc. Monitor fetal HR Look for fetal, maternal distress, ut.scar*

Induction & Augmentation     

Oxytocin DOC i.v. infusion pump Dilution-5 IU in 500ml NS/Glucose 0.2-2ml/mt. depending on response Precautions→ Monitor mother and fetus. Over stimulation → Discontinue*

Why Oxytocin? Why not Ergometrine?

1. Short t ½ 2. Normal relaxation of uterus allowedGood fetal oxygenation 3. Lower segment not affected-descent free 4. Consistent augmentation in ut.inertia*

Other uses 1. Third stage of labour, puerperium: (Post partum hemorrhage) 5 IU i.m or i.v infusion. Other drugs→Ergometrine, Misoprostol 3. Breast engorgement: Nasal spray before suckling 4. Oxytocin challenge test: To assess placental insufficiency • AD.Effects: Rupture ut. Fetal distress, maternal injury*

Desamino-oxytocin

• Buccal formulation, uses same as oxytocin, less consistent action*

Ergometrine and Methyl ergometrine • Amine ergot alkaloid and methyl derivative. • Increase force, frequency, duration of ut.contractions • Moderate increase of dose → Basal tone increased • Lower segment also contracts. • 5HT2, α Adre.agonist • Methyl ergometrine more potent action on uterus and less on CVS, CNS, GIT etc.*

Ad. Effects: • Methyl ergometrine less toxic Nausea, vomiting, rise in BP. Decreases milk secretion Avoided in  Vascular disease, HTN, toxemia  Sepsis→gangrene  Liver and kidney disease.*  [Safe in ob.doses]

C.I.in pregnancy & early stages of labour

Uses: • PPH→ After anterior shoulder presentation  Prevention → 0.2-0.3 mg i.m  Treatment → 0.5 mg i.v. 4. Prevent uterine atony[cesarian, instrument] 5. To promote involution in multipara → 0.125mg TDS -7days 6. Diagnosis of variant angina during Coronary angio*

•The "Four Ts" for Causes of Postpartum Hemorrhage

•Four Ts Tone Trauma

Tissue Thrombin

Cause Atonic uterus

Approximate incidence (%) 70

Lacerations, 20 hematomas, inversion, rupture Retained tissue, 10 invasive placenta Coagulopathies 1

Ergometrine

Prostaglandins • PGE2 (Dinoprostone)→ Vaginal application → Induce II trimester abortion, missed abortion, ripening of cervix in near term • Preperations Misoprostol → with mifepristone for early abortion 15-Methyl-PGF2α (Carboprost) → II trimester abortions Facilitate labour- Unlabelled use in cardiac, renal disease, eclampsia*

Uterine relaxants[Tocolytics]

• Adrenergic agonists[β2] • Ca++ channel blockers • Magnesium sulfate • Atosiban • Others*

Adrenergic agonists: • Ritodrine: Ritodrine is a Beta-2 agonist  ADE:  CVS Metaboloic Use: To delay labour  I.v infusion 50μg/mt  CI: Heart disease, diabetes, on beta blockers. • Others: Isoxsuprine*

• Magnesium sulfate: • Not routinely used because of toxicity. [eclampsia-for siezures] Ca++ channel blockers:  Reduced Ca entry → Reduced tone  Nifedipine → 10mg every 30 mts Atosiban: Antagonist of oxytocin receptors Others: Ethyl alcohol, nitrates, Halothane etc.*

Indications & Contraindications for tocolytics

Ind: Delay preterm labour CI: More than 37 weeks gestation Fetus >2500g Fetus in distress Cx dilation > 4 cm Ruptured membrane Toxemia, Cardiac diseases 

Related Documents